Tag: global adme toxicology testing market

Uncover key drivers, emerging technologies, and competitive movements shaping the adme toxicology testing market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the ADME Toxicology Testing Market between 2026 and 2030?

The adme toxicology testing market size has recently experienced significant expansion. It is projected to grow from $11.5 billion in 2025 to $12.83 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.6%. In the historic period, this growth was primarily driven by factors including the limited availability of automated adme testing systems, a reliance on traditional biochemical assays, an increasing regulatory focus on drug safety, growing pharmaceutical research initiatives, and the adoption of LC-MS and HPLC instruments.

The adme toxicology testing market is projected for significant expansion in the coming years. It is set to reach $20.25 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.1%. This growth during the forecast period can be attributed to the development of integrated adme platforms, the rising application of omics and molecular imaging technologies, increasing investment in predictive toxicology software, the expansion of adme testing into the cosmetics and food industries, and the adoption of AI-driven risk assessment solutions. Major trends anticipated over this period include the growing adoption of high-throughput screening instruments, an increasing use of cell-based and in vitro assays, rising demand for omics-based toxicology technologies, the expansion of adme testing in pharmaceutical development, and the integration of simulation and modeling software in risk assessment.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11922&type=smp

Which Drivers Are Expected To Impact The ADME Toxicology Testing Market During The Forecast Period?

The increasing need for new pharmaceutical substances is anticipated to boost the expansion of the ADME toxicology testing market in the future. Novel drugs are defined as pharmaceutical compounds not previously sanctioned or sold for medical applications. ADME toxicity testing constitutes a vital phase in drug development, guaranteeing the safety of these novel drugs and confirming they do not generate adverse toxins within the body. For example, as reported in January 2024 by the Center for Drug Evaluation and Research (CDER), a US-based division of the U.S. Food and Drug Administration (FDA), in their New Drug Therapy Approvals 2023 report, the CDER sanctioned 55 novel drugs in 2023, of which 20 (36%) were categorized as first-in-class, an increase from 37 novel drug approvals in 2022. Consequently, the growing demand for novel drugs is fueling the growth of the ADME toxicology testing market. The expansion of the pharmaceutical industry is projected to advance the ADME toxicology testing market in the coming years. The pharmaceutical industry encompasses a segment dedicated to the identification, formulation, and manufacturing of drugs and medications by both public and private organizations. ADME toxicology testing is employed by this industry to determine the absorption, distribution, metabolism, and excretion (ADME) characteristics of potential drug compounds and to gauge their possible toxicity. This assessment is vital for foreseeing a drug’s actions within the human system, including its rates of absorption, dissemination to specific tissues, metabolic processes, and removal from the body. As an illustration, in June 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade group representing the European pharmaceutical industry, reported that Europe’s overall pharmaceutical output reached €390,000 million ($422,803 million) in 2023, an increase from €363,300 million ($393,857 million) in 2022. Consequently, the expanding pharmaceutical industry is propelling the ADME toxicology testing market’s growth.

Which Segments Are Driving Activity In The ADME Toxicology Testing Market?

The adme toxicology testing market covered in this report is segmented –

1) By Product Type: Instruments, Software Solutions, Assays Systems, Reagents, Other Product Types

2) By Method: Cellular Assay, Biochemical Assay, In Silica, Ex-Vivo

3) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology, Other Technologies

4) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications

5) By End-User: Cosmetics And Household Products, Pharmaceutical Industry, Animal Industry, Food Industry, Other End Users

Subsegments:

1) By Instruments: High-Throughput Screening Instruments, LC-MS Or MS (Liquid Chromatography-Mass Spectrometry), HPLC (High-Performance Liquid Chromatography), Automated Workstations

2) By Software Solutions: Data Management Software, Simulation And Modeling Software, Risk Assessment Software

3) By Assay Systems: Cell-Based Assays, In Vitro Assays, Bioanalytical Assays

4) By Reagents: Biochemicals, Buffer Solutions, Culture Media

5) By Other Products: Kits And Consumables, Analytical Standards

What Industry Trends Are Transforming The ADME Toxicology Testing Market?

Leading companies within the ADME toxicology testing market are implementing advanced technologies, such as the Cyprotex e-Store, to enable online ordering of ADME-Tox services. The primary goal of ADME-Tox services is to save development costs and time, minimize the chance of failure in later stages, and facilitate the selection of the most promising candidate for clinical development. For example, in October 2023, Evotec SE, a Germany-based biotechnology company, launched the Cyprotex e-Store. This e-commerce platform provides simplified online access to the company’s wide array of ADME-Tox services. The e-Store streamlines and speeds up the acquisition process, letting registered users assess and order Cyprotex’s offerings continuously, twenty-four hours a day, seven days a week. It offers immediate online access to prices and comprehensive protocols, allowing users to effortlessly place orders, track their status, and reorder when necessary. This efficient platform shortens the lead time for services, enabling users to receive their data more quickly.

Which Major Industry Participants Are Leading The ADME Toxicology Testing Market Growth?

Major companies operating in the adme toxicology testing market are AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Laboratory Corporation of America Holdings, Corning Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Lonza Group AG, Dassault Systèmes SE, Catalent Inc., Charles River Laboratories International Inc., Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Curia Global Inc, Promega Corporation, Takara Bio Inc, AB Sciex LLC, QPS Holdings LLC, Simulations Plus Inc., Cyprotex, XenoTech LLC, BioIVT LLC, Absorption Systems, Creative Bioarray, SOLVO Biotechnology Rt., Creative Biolabs Inc, Gentronix Limited, Admecell Inc., Molecular Discovery Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The ADME Toxicology Testing Market?

North America was the largest region in the ADME toxicology testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adme toxicology testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized ADME Toxicology Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=11922&type=smp

Browse Through More Reports Similar to the Global ADME Toxicology Testing Market 2026, By The Business Research Company

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Pharma Admet Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

Genetic Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the adme toxicology testing market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the ADME Toxicology Testing Market between 2026 and 2030?

The adme toxicology testing market size has recently experienced significant expansion. It is projected to grow from $11.5 billion in 2025 to $12.83 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.6%. In the historic period, this growth was primarily driven by factors including the limited availability of automated adme testing systems, a reliance on traditional biochemical assays, an increasing regulatory focus on drug safety, growing pharmaceutical research initiatives, and the adoption of LC-MS and HPLC instruments.

The adme toxicology testing market is projected for significant expansion in the coming years. It is set to reach $20.25 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.1%. This growth during the forecast period can be attributed to the development of integrated adme platforms, the rising application of omics and molecular imaging technologies, increasing investment in predictive toxicology software, the expansion of adme testing into the cosmetics and food industries, and the adoption of AI-driven risk assessment solutions. Major trends anticipated over this period include the growing adoption of high-throughput screening instruments, an increasing use of cell-based and in vitro assays, rising demand for omics-based toxicology technologies, the expansion of adme testing in pharmaceutical development, and the integration of simulation and modeling software in risk assessment.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11922&type=smp

Which Drivers Are Expected To Impact The ADME Toxicology Testing Market During The Forecast Period?

The increasing need for new pharmaceutical substances is anticipated to boost the expansion of the ADME toxicology testing market in the future. Novel drugs are defined as pharmaceutical compounds not previously sanctioned or sold for medical applications. ADME toxicity testing constitutes a vital phase in drug development, guaranteeing the safety of these novel drugs and confirming they do not generate adverse toxins within the body. For example, as reported in January 2024 by the Center for Drug Evaluation and Research (CDER), a US-based division of the U.S. Food and Drug Administration (FDA), in their New Drug Therapy Approvals 2023 report, the CDER sanctioned 55 novel drugs in 2023, of which 20 (36%) were categorized as first-in-class, an increase from 37 novel drug approvals in 2022. Consequently, the growing demand for novel drugs is fueling the growth of the ADME toxicology testing market. The expansion of the pharmaceutical industry is projected to advance the ADME toxicology testing market in the coming years. The pharmaceutical industry encompasses a segment dedicated to the identification, formulation, and manufacturing of drugs and medications by both public and private organizations. ADME toxicology testing is employed by this industry to determine the absorption, distribution, metabolism, and excretion (ADME) characteristics of potential drug compounds and to gauge their possible toxicity. This assessment is vital for foreseeing a drug’s actions within the human system, including its rates of absorption, dissemination to specific tissues, metabolic processes, and removal from the body. As an illustration, in June 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade group representing the European pharmaceutical industry, reported that Europe’s overall pharmaceutical output reached €390,000 million ($422,803 million) in 2023, an increase from €363,300 million ($393,857 million) in 2022. Consequently, the expanding pharmaceutical industry is propelling the ADME toxicology testing market’s growth.

Which Segments Are Driving Activity In The ADME Toxicology Testing Market?

The adme toxicology testing market covered in this report is segmented –

1) By Product Type: Instruments, Software Solutions, Assays Systems, Reagents, Other Product Types

2) By Method: Cellular Assay, Biochemical Assay, In Silica, Ex-Vivo

3) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology, Other Technologies

4) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications

5) By End-User: Cosmetics And Household Products, Pharmaceutical Industry, Animal Industry, Food Industry, Other End Users

Subsegments:

1) By Instruments: High-Throughput Screening Instruments, LC-MS Or MS (Liquid Chromatography-Mass Spectrometry), HPLC (High-Performance Liquid Chromatography), Automated Workstations

2) By Software Solutions: Data Management Software, Simulation And Modeling Software, Risk Assessment Software

3) By Assay Systems: Cell-Based Assays, In Vitro Assays, Bioanalytical Assays

4) By Reagents: Biochemicals, Buffer Solutions, Culture Media

5) By Other Products: Kits And Consumables, Analytical Standards

What Industry Trends Are Transforming The ADME Toxicology Testing Market?

Leading companies within the ADME toxicology testing market are implementing advanced technologies, such as the Cyprotex e-Store, to enable online ordering of ADME-Tox services. The primary goal of ADME-Tox services is to save development costs and time, minimize the chance of failure in later stages, and facilitate the selection of the most promising candidate for clinical development. For example, in October 2023, Evotec SE, a Germany-based biotechnology company, launched the Cyprotex e-Store. This e-commerce platform provides simplified online access to the company’s wide array of ADME-Tox services. The e-Store streamlines and speeds up the acquisition process, letting registered users assess and order Cyprotex’s offerings continuously, twenty-four hours a day, seven days a week. It offers immediate online access to prices and comprehensive protocols, allowing users to effortlessly place orders, track their status, and reorder when necessary. This efficient platform shortens the lead time for services, enabling users to receive their data more quickly.

Which Major Industry Participants Are Leading The ADME Toxicology Testing Market Growth?

Major companies operating in the adme toxicology testing market are AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Laboratory Corporation of America Holdings, Corning Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Lonza Group AG, Dassault Systèmes SE, Catalent Inc., Charles River Laboratories International Inc., Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Curia Global Inc, Promega Corporation, Takara Bio Inc, AB Sciex LLC, QPS Holdings LLC, Simulations Plus Inc., Cyprotex, XenoTech LLC, BioIVT LLC, Absorption Systems, Creative Bioarray, SOLVO Biotechnology Rt., Creative Biolabs Inc, Gentronix Limited, Admecell Inc., Molecular Discovery Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The ADME Toxicology Testing Market?

North America was the largest region in the ADME toxicology testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adme toxicology testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized ADME Toxicology Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=11922&type=smp

Browse Through More Reports Similar to the Global ADME Toxicology Testing Market 2026, By The Business Research Company

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Pharma Admet Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

Genetic Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the adme toxicology testing market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the ADME Toxicology Testing Market between 2026 and 2030?

The adme toxicology testing market size has recently experienced significant expansion. It is projected to grow from $11.5 billion in 2025 to $12.83 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.6%. In the historic period, this growth was primarily driven by factors including the limited availability of automated adme testing systems, a reliance on traditional biochemical assays, an increasing regulatory focus on drug safety, growing pharmaceutical research initiatives, and the adoption of LC-MS and HPLC instruments.

The adme toxicology testing market is projected for significant expansion in the coming years. It is set to reach $20.25 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.1%. This growth during the forecast period can be attributed to the development of integrated adme platforms, the rising application of omics and molecular imaging technologies, increasing investment in predictive toxicology software, the expansion of adme testing into the cosmetics and food industries, and the adoption of AI-driven risk assessment solutions. Major trends anticipated over this period include the growing adoption of high-throughput screening instruments, an increasing use of cell-based and in vitro assays, rising demand for omics-based toxicology technologies, the expansion of adme testing in pharmaceutical development, and the integration of simulation and modeling software in risk assessment.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11922&type=smp

Which Drivers Are Expected To Impact The ADME Toxicology Testing Market During The Forecast Period?

The increasing need for new pharmaceutical substances is anticipated to boost the expansion of the ADME toxicology testing market in the future. Novel drugs are defined as pharmaceutical compounds not previously sanctioned or sold for medical applications. ADME toxicity testing constitutes a vital phase in drug development, guaranteeing the safety of these novel drugs and confirming they do not generate adverse toxins within the body. For example, as reported in January 2024 by the Center for Drug Evaluation and Research (CDER), a US-based division of the U.S. Food and Drug Administration (FDA), in their New Drug Therapy Approvals 2023 report, the CDER sanctioned 55 novel drugs in 2023, of which 20 (36%) were categorized as first-in-class, an increase from 37 novel drug approvals in 2022. Consequently, the growing demand for novel drugs is fueling the growth of the ADME toxicology testing market. The expansion of the pharmaceutical industry is projected to advance the ADME toxicology testing market in the coming years. The pharmaceutical industry encompasses a segment dedicated to the identification, formulation, and manufacturing of drugs and medications by both public and private organizations. ADME toxicology testing is employed by this industry to determine the absorption, distribution, metabolism, and excretion (ADME) characteristics of potential drug compounds and to gauge their possible toxicity. This assessment is vital for foreseeing a drug’s actions within the human system, including its rates of absorption, dissemination to specific tissues, metabolic processes, and removal from the body. As an illustration, in June 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade group representing the European pharmaceutical industry, reported that Europe’s overall pharmaceutical output reached €390,000 million ($422,803 million) in 2023, an increase from €363,300 million ($393,857 million) in 2022. Consequently, the expanding pharmaceutical industry is propelling the ADME toxicology testing market’s growth.

Which Segments Are Driving Activity In The ADME Toxicology Testing Market?

The adme toxicology testing market covered in this report is segmented –

1) By Product Type: Instruments, Software Solutions, Assays Systems, Reagents, Other Product Types

2) By Method: Cellular Assay, Biochemical Assay, In Silica, Ex-Vivo

3) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology, Other Technologies

4) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications

5) By End-User: Cosmetics And Household Products, Pharmaceutical Industry, Animal Industry, Food Industry, Other End Users

Subsegments:

1) By Instruments: High-Throughput Screening Instruments, LC-MS Or MS (Liquid Chromatography-Mass Spectrometry), HPLC (High-Performance Liquid Chromatography), Automated Workstations

2) By Software Solutions: Data Management Software, Simulation And Modeling Software, Risk Assessment Software

3) By Assay Systems: Cell-Based Assays, In Vitro Assays, Bioanalytical Assays

4) By Reagents: Biochemicals, Buffer Solutions, Culture Media

5) By Other Products: Kits And Consumables, Analytical Standards

What Industry Trends Are Transforming The ADME Toxicology Testing Market?

Leading companies within the ADME toxicology testing market are implementing advanced technologies, such as the Cyprotex e-Store, to enable online ordering of ADME-Tox services. The primary goal of ADME-Tox services is to save development costs and time, minimize the chance of failure in later stages, and facilitate the selection of the most promising candidate for clinical development. For example, in October 2023, Evotec SE, a Germany-based biotechnology company, launched the Cyprotex e-Store. This e-commerce platform provides simplified online access to the company’s wide array of ADME-Tox services. The e-Store streamlines and speeds up the acquisition process, letting registered users assess and order Cyprotex’s offerings continuously, twenty-four hours a day, seven days a week. It offers immediate online access to prices and comprehensive protocols, allowing users to effortlessly place orders, track their status, and reorder when necessary. This efficient platform shortens the lead time for services, enabling users to receive their data more quickly.

Which Major Industry Participants Are Leading The ADME Toxicology Testing Market Growth?

Major companies operating in the adme toxicology testing market are AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Laboratory Corporation of America Holdings, Corning Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Lonza Group AG, Dassault Systèmes SE, Catalent Inc., Charles River Laboratories International Inc., Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Curia Global Inc, Promega Corporation, Takara Bio Inc, AB Sciex LLC, QPS Holdings LLC, Simulations Plus Inc., Cyprotex, XenoTech LLC, BioIVT LLC, Absorption Systems, Creative Bioarray, SOLVO Biotechnology Rt., Creative Biolabs Inc, Gentronix Limited, Admecell Inc., Molecular Discovery Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The ADME Toxicology Testing Market?

North America was the largest region in the ADME toxicology testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adme toxicology testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized ADME Toxicology Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=11922&type=smp

Browse Through More Reports Similar to the Global ADME Toxicology Testing Market 2026, By The Business Research Company

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Pharma Admet Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

Genetic Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The ADME Toxicology Testing Industry Expected To Reach By 2029, Starting From 2025 Levels?

The adme toxicology testing market size has seen a rapid increase in recent years. It is projected to expand from $10.4 billion in 2024 to reach $11.5 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 10.5%. This historical growth is largely due to factors such as stringent regulatory demands, an uptick in drug development endeavors, heightened awareness regarding drug safety, improvements in in vitro testing techniques, and a surge in the outsourcing of toxicology assessments.

The adme toxicology testing market is projected to experience substantial growth over the coming years. This market is anticipated to reach $17.98 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.8%. Key factors driving this expansion during the forecast period include the swift growth of biopharmaceuticals, a rising focus on personalized medicine, the development of advanced therapies, improved predictive toxicology models, and a worldwide increase in chemical safety testing. Significant trends expected within the forecast period encompass broader applications of biomarkers, the integration of multi-omics data, increased regulatory focus on in vitro testing, strategic collaborations and partnerships, and ongoing technological progress.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11922&type=smp

Which Factors And Drivers Are Influencing The ADME Toxicology Testing Market In 2025?

The increasing demand for novel drugs is projected to fuel the expansion of the ADME toxicology testing market in the future. Novel drugs are defined as pharmaceutical compounds that have not been previously approved or introduced to the market for therapeutic purposes. ADME toxicity testing plays a vital role in drug development to confirm that the novel drug is safe and does not produce any harmful toxins within the body. For instance, in January 2024, data from the New Drug Therapy Approvals 2023 report, published by the Center for Drug Evaluation and Research (CDER), a US-based branch of the U.S. Food and Drug Administration (FDA), revealed that the CDER approved 55 novel drugs in 2023, with 20 (36%) identified as first-in-class, which is an increase compared to 37 novel drug approvals in 2022. Therefore, the growing need for novel drugs is propelling the growth of the ADME toxicology testing market.

What Are The Primary Types Of Segments Analyzed In The ADME Toxicology Testing Market?

The adme toxicology testingmarket covered in this report is segmented –

1) By Product Type: Instruments; Software Solutions; Assays Systems; Reagents; Other Products

2) By Method: Cellular Assay; Biochemical Assay; In Silica; Ex-Vivo

3) By Technology: Cell Culture; High Throughput; Molecular Imaging; OMICS Technology; Other Technologies

4) By Application: Systemic Toxicity; Renal Toxicity; Hepatotoxicity; Neurotoxicity; Other Applications

5) By End-User: Cosmetics And Household Products; Pharmaceutical Industry; Animal Industry; Food Industry; Other End Users

Subsegments:

1) By Instruments: High-Throughput Screening Instruments; LC-MS Or MS (Liquid Chromatography-Mass Spectrometry); HPLC (High-Performance Liquid Chromatography); Automated Workstations

2) By Software Solutions: Data Management Software; Simulation And Modeling Software; Risk Assessment Software

3) By Assay Systems: Cell-Based Assays; In Vitro Assays; Bioanalytical Assays

4) By Reagents: Biochemicals; Buffer Solutions; Culture Media

5) By Other Products: Kits And Consumables; Analytical Standards

Which Ongoing Trends Are Expected To Shape The ADME Toxicology Testing Market Outlook?

Technological advancements represent a significant trend gaining traction within the ADME toxicology testing market. Leading companies operating in the ADME toxicology testing market are introducing innovative assay solutions that leverage advanced technologies, such as Logica, to maintain their competitive position. For instance, in April 2022, Charles River Laboratories International Inc., a US-based pharmaceutical company, and Valo Health Inc., a US-based AI-health solution company, jointly launched Logica. This AI-based drug development solution utilizes Valo’s AI-powered Opal Computational Platform to deliver ADME toxicology testing services to users, in addition to other drug delivery solutions.

Who Are The Core Companies Influencing The ADME Toxicology Testing Market Landscape?

Major companies operating in the ADME toxicology testing market include AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Laboratory Corporation of America Holdings, Corning Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Lonza Group AG, Dassault Systèmes SE, Catalent Inc., Charles River Laboratories International Inc., Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Curia Global Inc, Promega Corporation, Takara Bio Inc, AB Sciex LLC, QPS Holdings LLC, Simulations Plus Inc., Cyprotex, XenoTech LLC, BioIVT LLC, Absorption Systems, Creative Bioarray, SOLVO Biotechnology Rt., Creative Biolabs Inc, Gentronix Limited, Admecell Inc., Molecular Discovery Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

What Are The Key Regional Factors Influencing The ADME Toxicology Testing Market Growth?

North America was the largest region in the ADME toxicology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ADME toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The ADME Toxicology Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=11922&type=smp

Browse Through More Reports Similar to the Global ADME Toxicology Testing Market 2025, By The Business Research Company

Frozen Fruit And Vegetable Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/frozen-fruit-and-vegetable-global-market-report

Dairy Food Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dairy-food-global-market-report

Perishable Prepared Food Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/perishable-prepared-food-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the ADME Toxicology Testing Market In 2029?

In recent years, the adme toxicology testing market has seen a significant surge in its size. The market which was valued at $10.4 billion in 2024 is set to rise to $11.5 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.5%. Factors such as strict regulatory mandates, an increase in drug development activities, escalating concerns over drug safety, progress in in vitro testing techniques, and a rise in the outsourcing of toxicology studies have been instrumental in this historical growth period.

Anticipations are high for a swift expansion in the adme toxicology testing market in the upcoming years. Forecasts predict that the market will escalate to$17.98 billion by 2029 with a compound annual growth rate (CAGR) of 11.8%. The rapid proliferation of biopharmaceuticals, an increasing focus on personalized medicine, the advent of innovative therapies, improved predictive toxicology models, and a worldwide increment in chemical safety testing have been identified as the drivers of growth within the predicted period. Other defining trends to watch for within this period include the enlargement of biomarker applications, unification of multi-omics data, regulatory focus on in vitro testing, collaborations and partnerships, and ceaseless advancements in technology.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11922&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theADME Toxicology Testing Market?

The growth of the ADME toxicology testing market is anticipated to be driven by the escalating desire for novel drugs. Such drugs pertain to pharmaceutical substances yet to receive approval or hit the market for therapeutic applications. ADME toxicity testing stands as a crucial stage in the development of a drug, aimed at affirming the safety of the new drug and ensuring it doesn’t generate any harmful toxins within the organism. For example, the New Drug Therapy Approvals 2023 report by the Center for Drug Evaluation and Research (CDER), a U.S. Food and Drug Administration (FDA) branch based in the US, indicated that in January 2024, the CDER approved 55 novel drugs during 2023, with 20 (36%) being recognized as first-in-class, as compared to 37 novel drug approvals during 2022. Hence, the thriving demand for novel drugs fuels the growth of the ADME toxicology testing market.

Which Segments in the ADME Toxicology Testing Offer the Most Growth?

The adme toxicology testingmarket covered in this report is segmented –

1) By Product Type: Instruments; Software Solutions; Assays Systems; Reagents; Other Products

2) By Method: Cellular Assay; Biochemical Assay; In Silica; Ex-Vivo

3) By Technology: Cell Culture; High Throughput; Molecular Imaging; OMICS Technology; Other Technologies

4) By Application: Systemic Toxicity; Renal Toxicity; Hepatotoxicity; Neurotoxicity; Other Applications

5) By End-User: Cosmetics And Household Products; Pharmaceutical Industry; Animal Industry; Food Industry; Other End Users

Subsegments:

1) By Instruments: High-Throughput Screening Instruments; LC-MS Or MS (Liquid Chromatography-Mass Spectrometry); HPLC (High-Performance Liquid Chromatography); Automated Workstations

2) By Software Solutions: Data Management Software; Simulation And Modeling Software; Risk Assessment Software

3) By Assay Systems: Cell-Based Assays; In Vitro Assays; Bioanalytical Assays

4) By Reagents: Biochemicals; Buffer Solutions; Culture Media

5) By Other Products: Kits And Consumables; Analytical Standards

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=11922&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theADME Toxicology Testing Market?# Market?

North America was the largest region in the ADME toxicology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ADME toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the ADME Toxicology Testing Industry?

In the ADME toxicology testing market, the increasing adoption of technological advancements is a prominent trend. To maintain their competitive edge in the market, leading corporations in the ADME toxicology testing field are unveiling unique assay solutions that utilize cutting-edge technologies such as Logica. For example, in April 2022, Charles River Laboratories International Inc., an American pharmaceutical establishment, and Valo Health Inc., an American AI-healthcare solutions firm, debuted Logica, a drug development solution powered by Artificial Intelligence. This innovative solution employs Valo’s AI-driven Opal Computational Platform to offer clients ADME toxicology testing services along with other drug delivery solutions.

View the full report here:

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

What Are the Key Elements That Define the ADME Toxicology Testing Market?

ADME toxicology testing is a set of studies conducted to assess the potential toxicity of a substance or drug candidate based on its absorption, distribution, metabolism, and excretion (ADME) properties. These tests are used in drug development to ensure the well-being of individuals exposed to substances.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11922

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the ADME Toxicology Testing Market Growth in 2025?

The market size of ADME toxicology testing has seen a substantial increase in the past few years. Predictions show an increase from $10.4 billion in 2024 up to $11.53 billion in 2025, implying a compound annual growth rate (CAGR) of 10.8%. The upsurge in the previous period is due to a combination of strict regulatory norms, an increase in drug development efforts, amplified concerns about drug safety, improvements in in vitro testing techniques, and a rise in the outsourcing of toxicology studies.

What Is the Forecast for the ADME Toxicology Testing Market Size Through 2029?

In the ensuing few years, the ADME toxicology testing market is anticipated to experience accelerated growth. Its projected size for 2029 is $18.06 billion, with a compound annual growth rate (CAGR) of 11.9%. Factors attributed to this growth within the future forecast span include the rapid enlargement of biopharmaceuticals, an increased focus on personalized medicine, the introduction of advanced therapies, improved predictive toxicology models, and a worldwide escalation in chemical safety testing. Some of the key trend predictions for this period entail the broadening of biomarker applications, amalgamation of multi-omics data, regulatory focus on in vitro testing, collaborative ventures and partnerships, alongside continual advancements in technology.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11922&type=smp

What are the Key Market Players in ADME Toxicology Testing Market and How They’re Evolving?

Major companies operating in the ADME toxicology testing market include AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Laboratory Corporation of America Holdings, Corning Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Lonza Group AG, Dassault Systèmes SE, Catalent Inc., Charles River Laboratories International Inc., Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Curia Global Inc, Promega Corporation, Takara Bio Inc, AB Sciex LLC, QPS Holdings LLC, Simulations Plus Inc., Cyprotex, XenoTech LLC, BioIVT LLC, Absorption Systems, Creative Bioarray, SOLVO Biotechnology Rt., Creative Biolabs Inc, Gentronix Limited, Admecell Inc., Molecular Discovery Ltd.

What Are the Primary Growth Drivers in the ADME Toxicology Testing Market?

The growth of the ADME toxicology testing market is anticipated to be fuelled by increasing demand for innovative drugs. These innovative drugs, not previously approved or used for therapeutic purposes, require ADME toxicity testing as a key step in their development process to ensure their safety and to confirm they don’t create any harmful toxins in the body. For example, the Center for Drug Evaluation and Research (CDER), a U.S. based department of the U.S. Food and Drug Administration (FDA), mentioned in their New Drug Therapy Approvals 2023 report that in January 2024, they approved 55 innovative drugs in 2023. Out of these, 20 (36%) were identified as being first-in-class. This showed an increase from 37 novel drug approvals in 2022. This amplifying demand for innovative drugs is thus fuelling the expansion of the ADME toxicology testing market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11922&type=smp

What Are the Leading Segments in the Global ADME Toxicology Testing Industry?

The ADME toxicology testing market covered in this report is segmented –

1) By Product Type: Instruments, Software Solutions, Assays Systems, Reagents, Other Products

2) By Method: Cellular Assay, Biochemical Assay, In Silica, Ex-Vivo

3) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology, Other Technologies

4) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications

5) By End-User: Cosmetics And Household Products, Pharmaceutical Industry, Animal Industry, Food Industry, Other End Users

Subsegments:

1) By Instruments: High-Throughput Screening Instruments, LC-MS Or MS (Liquid Chromatography-Mass Spectrometry), HPLC (High-Performance Liquid Chromatography), Automated Workstations

2) By Software Solutions: Data Management Software, Simulation And Modeling Software, Risk Assessment Software

3) By Assay Systems: Cell-Based Assays, In Vitro Assays, Bioanalytical Assays

4) By Reagents: Biochemicals, Buffer Solutions, Culture Media

5) By Other Products: Kits And Consumables, Analytical Standards

What Are the Key Market Trends in the ADME Toxicology Testing Industry?

The rise of technological advancements is a significant trend witnessed in the ADME toxicology testing market. Renowned corporations within this market are focusing on the deployment of cutting-edge assay solutions, like Logica, to maintain their competitive stance. For example, in April 2022, Charles River Laboratories International Inc., an American pharmaceutical firm, along with Valo Health Inc., a US-based company specializing in AI-health solutions, unveiled Logica, a solution for drug development sourced from AI. This new introduction harnesses the AI-powered Opal Computational Platform from Valo to offer ADME toxicology testing services and other drug delivery options to its users.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

What Is the Regional Outlook for the ADME Toxicology Testing Market?

North America was the largest region in the ADME toxicology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ADME toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11922

This Report Delivers Insight On:

1. How big is the adme toxicology testing market, and how is it changing globally?

2. Who are the major companies in the adme toxicology testing market, and how are they performing?

3. What are the key opportunities and risks in the adme toxicology testing market right now?

4. Which products or customer segments are growing the most in the adme toxicology testing market?

5. What factors are helping or slowing down the growth of the adme toxicology testing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model